公司问答丨南新制药：公司盐酸左沙丁胺醇雾化吸入溶液项目已提交上市申请并通过现场核查

Core Viewpoint - The company has submitted a marketing application for its nebulized solution of Levosalbutamol and has passed the on-site inspection, aiming for an early market launch [1] Group 1 - The company responded to an investor inquiry regarding which research and development project is closest to market launch [1] - The company is actively following up on the application status and is committed to bringing the product to market as soon as possible [1]